Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Pack
Recalled July 29, 2026 · FDA recall D-0711-2026 · Major Pharmaceuticals
Hazard
Subpotent Drug · FDA Class II
Units
N/A
Sold at
Nationwide in the USA.
Description
Subpotent Drug
Product
Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3563-0; NDC Blister: 0904-6956-61
Manufacturer(s)
Major Pharmaceuticals
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →